Glenmark Pharmaceuticals consolidated net profit rises 15.88% in the December 2025 quarter
Sales rise 17.75% to Rs 3888.00 crore
Net profit of Glenmark Pharmaceuticals rose 15.88% to Rs 403.21 crore in the quarter ended December 2025 as against Rs 347.96 crore during the previous quarter ended December 2024. Sales rose 17.75% to Rs 3888.00 crore in the quarter ended December 2025 as against Rs 3301.90 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales3888.003301.90 18 OPM %22.3718.18 -PBDT872.79579.06 51 PBT718.34456.33 57 NP403.21347.96 16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content